CORRECTION article

Front. Oncol., 15 December 2023

Sec. Women's Cancer

Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1302413

Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy

  • 1. Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India

  • 2. Department of Anatomy and Cell Biology, Cancer and Genetics Research Complex, University of Florida, Gainesville, FL, United States

  • 3. The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel

  • 4. Department of Biotechnology and Microbiology, Kannur University, Kannur, India

  • 5. Department of Biotechnology, University of Calicut, Malappuram, India

  • 6. Department of Pathology, Government Medical College, Kottayam, India

Article metrics

View details

1,3k

Views

410

Downloads

In the published article, there was an error in Figure 5A(i) and Figure 5D(ii) as published. The image of excised tumor of animal treated with curcumin that is present in Figure 2A was wrongly placed as image of excised tumor in the control group in Figure 5A(i). In Figure 5D(ii), an error happened during the cropping and placing of the IHC images. The IHC image depicting the expression status of TS in curcumin-treated tumor samples of MDA-MB-231 TS-ve panel was accidentally duplicated and the same image was placed as IHC image depicting the expression status of p-p65 in curcumin-treated tumor samples of MDA-MB-231 TS-ve panel. We have rectified this mistake in the revised Figure 5 and the duplicated images have been replaced by the correct ones. The corrected Figure 5 and its caption appear below.

Figure 5

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

breast cancer, thymidylate synthase, chemoresistance, chemosensitization, curcumin, 5-FU

Citation

Haritha NH, Nawab A, Vijayakurup V, Anto NP, Liju VB, Alex VV, Amrutha AN, Aiswarya SU, Swetha M, Vinod BS, Sundaram S, Guijarro MV, Herlevich T, Krishna A, Nestory NK, Bava SV, Sadasivan C, Zajac-Kaye M and Anto RJ (2023) Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy. Front. Oncol. 13:1302413. doi: 10.3389/fonc.2023.1302413

Received

26 September 2023

Accepted

27 October 2023

Published

15 December 2023

Approved by

Sophia George, University of Miami, United States

Volume

13 - 2023

Updates

Copyright

*Correspondence: Ruby John Anto,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics